PARTHENON THERAPEUTICS
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as manycancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on research, the company is designing a portfolio of drug candidates to treat the right patients at the right time.
PARTHENON THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.parthenontx.com
Total Employee:
11+
Status:
Active
Total Funding:
65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Trident Bioscience
Trident Bioscience is a biotech company that stays abreast of the latest technological trends in leading protein structure.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Parthenon Therapeutics
Park West Asset Management
Park West Asset Management investment in Series A - Parthenon Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Parthenon Therapeutics
Creacion Ventures
Creacion Ventures investment in Series A - Parthenon Therapeutics
Breakout Ventures
Breakout Ventures investment in Series A - Parthenon Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series A - Parthenon Therapeutics
KdT Ventures
KdT Ventures investment in Series A - Parthenon Therapeutics
Section 32
Section 32 investment in Series A - Parthenon Therapeutics
Northpond Ventures
Northpond Ventures investment in Series A - Parthenon Therapeutics
Taiho Ventures
Taiho Ventures investment in Series A - Parthenon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-01 | Parthenon Therapeutics Appoints Tamas Oravecz, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.parthenontx.com Semrush global rank: 2.5 M Semrush visits lastest month: 7.03 K
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Parthenon Therapeutics"
Parthenon Therapeutics - Crunchbase Company Profile …
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.See details»
EY Canada announces major expansion of EY …
1 day ago EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity.See details»
Major expansion of EY-Parthenon strengthens EY position in …
2 days ago LONDON, 27 MARCH 2025. The EY organization today announces the expansion of EY-Parthenon, unifying the EY organization’s Strategy and Transactions service line under a …See details»
Parthenon Therapeutics Company Profile | Management and
Parthenon Therapeutics Profile and History Parthenon Therapeutics is a biotechnology company deploying our knowledge of complex biology and advanced technologies to deliver therapies …See details»
Parthenon Therapeutics - VentureRadar
VentureRadar Research / Company Website Dansk Biotek DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for …See details»
parthenontx.com
Parthenontx.comSee details»
Parthenon Therapeutics - Overview, News & Similar companies
Dec 14, 2022 View Parthenon Therapeutics (www.parthenontx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Parthenon Therapeutics Raises $65 Million in Series A …
Nov 3, 2021 Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announcedSee details»
Parthenon Therapeutics Co-Founder and COO, Olga …
Oct 12, 2022 Her dedication to addressing meaningful gaps extends beyond health to inspire and support women in their entrepreneurial pursuits both within Parthenon and beyond. Granaturova also elevates and supports women-led …See details»
Parthenon Technologies, Inc.
By continuing, you agree to our Terms of Use and Privacy Policy. Continue to SiteSee details»
Parthenon – Funding, Valuation, Investors, News
Oct 12, 2022 Essential stats, news, real-time insights on Parthenon. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Parthenon Therapeutics Showcases New Precision Oncology …
Nov 16, 2022 BOSTON-- (BUSINESS WIRE)--Parthenon Therapeutics, a precision oncology company inventing a novel class of anti-cancer therapies that reprogram the tumor …See details»
Major expansion of EY-Parthenon strengthens EY position in
1 hour ago Brad Watson to lead EY-Parthenon sub-brand in the MENA region Brand now comprises 25,000 professionals across 150 countries, supported by a US$250m investment in …See details»
Parthenon Therapeutics Announces First Patient Dosed in Phase 1 ...
Apr 25, 2023 BOSTON -- Parthenon Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), …See details»
Publications - parthenontx.com
ESMO Congress 2022: Cancer-Associated Fibroblasts correlate with Immune Phenotypes in Human Tumors September 9-13, 2022 by Travis Clifton SITC 2022: Discoidin Domain …See details»
How an acquisition helped Orifarm prepare a prescription for …
How an acquisition helped Orifarm prepare a prescription for growth EY-Parthenon teams help founder-run Orifarm, a Danish pharmaceuticals company, embark on the path to transformation.See details»
Transaction Strategy and Execution | EY - Canada
EY-Parthenon teams can support you with the development, evaluation and end-to-end execution of your transaction strategy. We deliver operational due diligence, deal management, …See details»
Organization of Teratology Information Specialists (OTIS)
The Organization of Teratology Information Specialists (OTIS) is made up of clinicians and researchers who answer inquiries from women and providers who have questions about …See details»
Profile of EY-Parthenon - Umbrex
Access a detailed profile of EY-Parthenon consulting: history, key figures, innovations, global presence, financials, and peer comparison.See details»
Parthenon Texas State - Facebook
Parthenon - Connecting Greeks to their faith Years ago, Trey Campbell, became a member of a Fraternity at Texas State University and found his way into Parthenon. Parthenon is a place …See details»